Navigation Links
BioMarin Announces Second Quarter 2011 Financial Results
Date:7/28/2011

t an expanded cohort of patients at the maximum tolerated dose.  The company has cleared a safety review after dosing the 5 mg/kg cohort and has authorization to start enrolling patients at 10 mg/kg.  Top-line results are expected in the second half of 2012.
  • BMN-673 (PARP inhibitor):  BioMarin has two ongoing trials for BMN-673.  In the first quarter of 2011, the company initiated a Phase I/II open-label trial of once daily, orally administered BMN-673 for advanced or recurrent solid tumors.  In July 2011, the company initiated a Phase I, two-arm, open-label, dose escalation study for BMN-673 for the treatment of patients with advanced hematological malignancies.  The primary objective of the studies is to establish the maximum tolerated dose of daily oral BMN-673 and to obtain preliminary efficacy data in an expanded cohort of patients with genetically-defined tumors.  

  • Preclinical Programs

  • BMN-111 for Achondroplasia: Regulatory interactions are underway, and BioMarin expects to initiate a Phase I trial by the first quarter of 2012.  BMN-111 is an analog of C-type Natriuretic Peptide (CNP), a small cyclic peptide that is a positive regulator of bone growth, for achondroplasia, the most common form of dwarfism.  There are approximately 18,000 to 24,000 patients in the U.S. and Europe, an estimated 25 percent of which could be candidates for treatment with a product like BMN-111.
  • Other early stage programs: BioMarin is working on multiple early development opportunities.

  • Non-GAAP Financial Information and ReconciliationThe above results for the three and six months ended June 30, 2011 and June 30, 2010 and financial guidance for the year ending December 31, 2011 are presented both as determined in accordance with GAAP and on a non-GAAP basis. As used in this release, non-GAAP income is based on GAAP Earnings Before Interest, Taxes, Depreciation
    '/>"/>

    SOURCE BioMarin Pharmaceutical Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

    Related medicine technology :

    1. BioMarin Partner AnGes MG, Inc. Submits BLA to Japanese Ministry of Health
    2. BioMarin Announces FDA Approval for Kuvan
    3. BioMarin Initiates Phase 1 Clinical Study of PEG-PAL in PKU
    4. BioMarin Announces Positive Results From Phase 2A Clinical Study of 6R-BH4 in Sickle Cell Disease
    5. BioMarin Initiates Phase 1/2 Clinical Trial for GALNS for Morquio A Syndrome
    6. BioMarin Initiates Phase 2 Clinical Study of PEG-PAL in PKU
    7. BioMarin Acquires Huxley Pharmaceuticals, Inc.
    8. BioMarin to Present at the Oppenheimer Healthcare Conference
    9. BioMarin Announces Third Quarter 2009 Financial Results
    10. BioMarin to Acquire LEAD Therapeutics
    11. BioMarin to Present at the Credit Suisse Healthcare Conference
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/1/2015)... Pa. , July 1, 2015 ... fully integrated specialty pharmaceutical company focused on developing, ... that Bob Radie , president and chief ... conferences this summer. He will provide an update ... (ketorolac tromethamine) Nasal Spray, approved product ...
    (Date:7/1/2015)... July 1, 2015 New exchange plan enrollees ... 2015 compared to the same time a year ago, ... (NASDAQ: ESRX ) Exchange Pulse™ report, released today. ... 2014, the number of new exchange plan enrollees who ... in the first quarter of 2015. However, when evaluating ...
    (Date:7/1/2015)... The Haselmeier Group has decided ... Gert Weber has been nominated by the Board ... Executive Officer (CEO) of the Haselmeier Group. This ... Mr. Weber brings more than 20 years of experience ... various executive management positions, the last being Managing Director ...
    Breaking Medicine Technology:Egalet to Present at Upcoming Conferences This Summer 2Egalet to Present at Upcoming Conferences This Summer 3Express Scripts Provides First Look at 2015 Public Exchange Pharmacy Trends 2Express Scripts Provides First Look at 2015 Public Exchange Pharmacy Trends 3Express Scripts Provides First Look at 2015 Public Exchange Pharmacy Trends 4Express Scripts Provides First Look at 2015 Public Exchange Pharmacy Trends 5Haselmeier Group Announces the Extension and Reorganization of its Executive Board 2
    ... 14 ERT (Nasdaq: ERES ) announced today that it will ... 2010 , after the market closes. After the release, the Company will host ... , , ... dial 1-800-860-2442 when calling within the United States or 1-412-858-4600 when ...
    ... PALO ALTO, Calif. , July 14 ... developed a medical device and procedure to treat vaginal ... accepted for the 2010 International Meetings for the International ... as a joint meeting in 2010, and the International ...
    Cached Medicine Technology:ERT to Announce Second Quarter 2010 Results on August 9, 2010 2Viveve-Sponsored Research Accepted for Presentation at Two Prestigious International Conferences 2Viveve-Sponsored Research Accepted for Presentation at Two Prestigious International Conferences 3
    (Date:7/1/2015)... NJ (PRWEB) , ... July 01, 2015 , ... ... , the global cancer enterprise of Hospital Corporation of America (HCA), as it ... and research, OncLive announced today. , With this new partnership, OncLive’s editorial ...
    (Date:7/1/2015)... ... July 01, 2015 , ... Did you know that infertility in ... Month, and we at Advanced Fertility Center of Texas (AFCT) would like to talk ... While infertility is often considered to be a “woman’s issue,” male fertility factors can ...
    (Date:7/1/2015)... ... July 01, 2015 , ... As if mood swings, cramps and ... significant number of women: leg pain. Northeast Houston Vein Center is offering tips on ... of venous reflux disease, is underdiagnosed and often overlooked. Many women experience the tiredness, ...
    (Date:7/1/2015)... ... July 01, 2015 , ... Trevor L. Williams, DMD holds a Bachelor of ... USF earning a Master’s degree in Microbiology. He graduated from the University of Florida ... Association, the Florida Dental Association and the Academy of General Dentistry. Dr. Williams was ...
    (Date:7/1/2015)... ... July 01, 2015 , ... ... IBM software products, announced today that it has received trademark protection for its ... and detailed analysis of data from multiple sources providing an environment where users ...
    Breaking Medicine News(10 mins):Health News:OncLive® Welcomes Sarah Cannon Cancer Network to Its Strategic Alliance Partnership Program 2Health News:OncLive® Welcomes Sarah Cannon Cancer Network to Its Strategic Alliance Partnership Program 3Health News:Male Fertility: Improve Testosterone and Fertility With Natural Approaches 2Health News:Male Fertility: Improve Testosterone and Fertility With Natural Approaches 3Health News:Male Fertility: Improve Testosterone and Fertility With Natural Approaches 4Health News:Northeast Houston Vein Center Offers Tips for Women with Leg Pain 2Health News:Northeast Houston Vein Center Offers Tips for Women with Leg Pain 3Health News:Trevor L. Williams, D.M.D. Joins Enlow & Vance Dental Partners in Tampa, Florida 2Health News:Element Blue Receives Trademark Protection from U.S. Patent and Trademark Office for Its Award Winning SensorInsight® Software 2Health News:Element Blue Receives Trademark Protection from U.S. Patent and Trademark Office for Its Award Winning SensorInsight® Software 3Health News:Element Blue Receives Trademark Protection from U.S. Patent and Trademark Office for Its Award Winning SensorInsight® Software 4
    ... The decision by President Barack Obama to reverse ... Cardinal Justin Rigali, chairman of the U.S. Bishops, ... 23, after President Obama issued the executive order ... promote abortion in developing nations. Cardinal Rigali,s statement ...
    ... -- Congressman Howard L. Berman (D-CA), ... today President Obama,s executive order repealing the Mexico ... women,s rights and in improving health care worldwide."The ... eight years has hindered people in developing countries ...
    ... in Oak Brook , ... Perinatal Nursing Advisory Council and the March of Dimes invites nurses, ... the community to the March of Dimes 34th Annual Perinatal ... All healthcare professionals caring for moms and babies are ...
    ... of inflammatory bowel disease have higher concentrations of folate in ... study led by researchers at the University of California, San ... previously held theory that patients with IBD are prone to ... "This is exciting work that opens the door to additional ...
    ... TO PRESIDENT,S CALL TO ACTIONWASHINGTON, Jan. 23 ... people in this country participating in volunteer events on ... Two of the most popular Red Cross events were ... Red Cross Ready." , , (Logo: ...
    ... Links Patients With Researchers, CliniciansMIDDLETOWN, Ohio, Jan. 23 ... of Parent Project Muscular Dystrophy (PPMD), the largest ... finding a cure for Duchenne muscular dystrophy (Duchenne), ... central online arena linking the resources and needs ...
    Cached Medicine News:Health News:March of Dimes 34th Annual Perinatal Conference For Nurses, Health Educators, Social Workers and Other Healthcare Pros Caring for Moms and Babies 2Health News:Children with inflammatory bowel disease have surprisingly high folate levels, study finds 2Health News:Children with inflammatory bowel disease have surprisingly high folate levels, study finds 3Health News:Red Cross: Records Set On Day of Service 2Health News:DuchenneConnect Celebrates One Year Anniversary 2Health News:DuchenneConnect Celebrates One Year Anniversary 3Health News:DuchenneConnect Celebrates One Year Anniversary 4
    ... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
    ... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
    ... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
    ... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
    Medicine Products: